V

    Vericel Corp Ord (VCEL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $39.90
    -1.05 (-2.56%)

    Market Cap: $2.10B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    +59.19%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.06
    Range$0.02 - $0.10
    5 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.07+28.0%
    60d ago$0.09+51.8%
    30d ago$0.08+46.4%
    7d ago$0.08+46.4%
    Current$0.06
    Revenue Consensus
    $78M
    Range$77M - $78M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.64
    Range$0.57 - $0.83
    5 analysts
    Revenue Consensus
    $122M
    Range$121M - $126M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.64---
    Sep 26EST
    		-$0.06---
    Jun 26
    Reported Jul 30
    		$0.04$-0.04+200.00%Beat+500.0%
    Mar 26
    Reported May 7
    		$-0.12$-0.16+25.00%Beat+47.8%
    Dec 25
    Reported Feb 26
    		$0.45$0.45+0.00%Beat+18.4%
    Sep 25
    Reported Nov 6
    		$0.10$-0.01+1100.00%Beat+600.0%
    Jun 25
    Reported Jul 31
    		$-0.01N/A+75.00%Beat+90.0%
    Mar 25
    Reported May 8
    		$-0.23$-0.15-53.33%Miss-187.5%
    Dec 24
    Reported Feb 27
    		$0.38$0.34+11.76%Beat+46.2%
    Sep 24
    Reported Nov 7
    		$-0.02N/A+60.00%Beat+60.0%
    Jun 24
    Reported Aug 1
    		$-0.10$-0.09-11.11%Miss+9.1%
    Mar 24
    Reported May 8
    		$-0.08$-0.10+20.00%Beat+50.0%
    Dec 23
    Reported Feb 29
    		$0.26$0.17+52.94%Beat+116.7%
    Sep 23
    Reported Nov 8
    		$-0.05N/A+58.33%Beat+64.3%
    Jun 23
    Reported Aug 2
    		$-0.11$-0.15+26.67%Beat+42.1%
    Mar 23
    Reported May 10
    		$-0.16$-0.16+0.00%Beat-6.7%
    Dec 22
    Reported Feb 23
    		$0.12$0.04+200.00%Beat+33.3%
    Sep 22
    Reported Nov 9
    		$-0.14$-0.10-40.00%Miss-27.3%
    Jun 22
    Reported Aug 3
    		$-0.19$-0.12-58.33%Miss-137.5%
    Mar 22
    Reported May 4
    		$-0.15$-0.12-25.00%Miss-114.3%
    Dec 21
    Reported Feb 24
    		$0.09$0.14-35.71%Miss-64.0%
    Sep 21
    Reported Nov 9
    		$-0.11$-0.02-450.00%Miss-237.5%
    Jun 21
    Reported Aug 4
    		$-0.08$-0.09+11.11%Beat+55.6%
    Mar 21
    Reported May 5
    		$-0.07$-0.04-75.00%Miss+30.0%
    Dec 20
    Reported Feb 24
    		$0.25$0.20+25.00%Beat+25.0%
    Sep 20
    Reported Nov 5
    		$0.08$-0.02+500.00%Beat+14.3%
    Jun 20
    Reported Aug 5
    		$-0.18$-0.20+10.00%Beat-260.0%
    Mar 20
    Reported May 5
    		$-0.10$-0.08-25.00%Miss-42.9%
    Dec 19
    Reported Feb 25
    		$0.20$0.20+0.00%Beat+53.8%
    Sep 19
    Reported Nov 5
    		$0.07$-0.02+450.00%Beat+450.0%
    Jun 19
    Reported Aug 6
    		$-0.05$-0.06+16.67%Beat+58.3%
    Mar 19
    Reported May 7
    		$-0.07$-0.07+0.00%Beat+66.7%
    Dec 18
    Reported Feb 26
    		$0.13$0.04+225.00%Beat+333.3%
    Sep 18
    Reported Nov 6
    		$-0.02N/A+81.82%Beat+84.6%
    Jun 18
    Reported Aug 6
    		$-0.12$-0.12+0.00%Beat-71.4%
    Mar 18
    Reported May 8
    		$-0.21$-0.13-61.54%Miss+32.3%
    Dec 17
    Reported Mar 5
    		$0.03N/A+142.86%Beat+113.0%
    Sep 17
    Reported Nov 7
    		$-0.13$-0.16+18.75%Beat+51.9%
    Jun 17
    Reported Aug 9
    		$-0.07N/A+63.16%Beat-
    Mar 17
    Reported May 10
    		$-0.31$-0.16-93.75%Miss-
    Dec 16
    Reported Mar 10
    		$-0.23$-0.18-27.78%Miss-
    Sep 16
    Reported Nov 7
    		$-0.27$-0.18-50.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio84.89EV/EBITDA52.77x
    Price/FCF33.05xFCF Yield3.03%
    Profitability
    Profit Margin7.91%Operating Margin0.56%
    ROE7.16%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage28.47x
    Current Ratio5.04xQuick Ratio4.69x
    Trading Statistics
    Beta1.07Avg Volume479.34K
    52-Week High$49.3252-Week Low$28.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$42.26
    SMA 20$43.48
    SMA 50$44.77
    SMA 200$38.14
    EMA 10$42.05
    EMA 20$43.05
    EMA 50$42.99
    EMA 200$39.64

    MACD

    Line: -1.00Signal: -0.58Hist: -0.43

    ADX

    ADX: 15.9+DI: 14.8-DI: 28.4

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$44.45

    Bollinger Bands

    Upper Band$46.73
    Lower Band$40.22
    %B Position1497%(Upper)
    Band Width-0.05

    RSI (14-Day)

    Neutral
    31.9

    Momentum Oscillators

    Stoch %K5.5
    Stoch %D10.4
    Williams %R-91.7
    ROC (10d)-8.5%
    Momentum-3.69
    CCI (20d)-183.1
    MFI (14d)43.3

    Volatility Measures

    ATR (14d)$1.51(3.8%)
    StdDev (20d)1.63
    Hist Vol25.9%(Moderate)

    Volume Flow

    VWAP$40.04
    OBV3.3M
    AD Line-488.7K
    CMF (20d)-0.154

    Volume Metrics

    Avg Vol (20d)478.4K
    Vol Ratio1.3x
    VWMA (20d)$43.28

    Pivot Points

    R3$42.40
    R2$41.93
    R1$41.44
    Pivot Point$40.97
    S1$40.48
    S2$40.02
    S3$39.53

    Advanced Oscillators

    TSI-20.20
    Ultimate Osc39.3
    KST-75.48

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$77.46M$68.42M$92.92M$67.50M$63.24M$52.60M$75.38M$57.91M$52.66M$51.28M$65.00M$45.58M
    Cost of Revenue$21.05M$19.16M$19.79M$17.92M$16.63M$16.32M$16.88M$16.25M$16.06M$15.93M$16.49M$14.97M
    Gross Profit$56.40M$49.27M$73.13M$49.59M$46.61M$36.27M$58.50M$41.65M$36.60M$35.35M$48.51M$30.61M
    Operating Expenses$55.97M$57.33M$50.71M$46.13M$48.64M$49.06M$40.02M$44.12M$42.63M$40.82M$35.78M$35.66M
    R&D$7.49M$8.10M$7.25M$6.32M$6.73M$7.26M$4.92M$6.09M$7.36M$6.42M$4.90M$5.68M
    SG&A$48.48M$49.23M$43.46M$39.82M$41.91M$41.80M$35.10M$38.02M$35.27M$34.40M$30.88M$29.99M
    Operating Income$434,000$-8,064,000$22.41M$3.45M$-2,029,000$-12,792,000$18.48M$-2,465,000$-6,031,000$-5,464,000$12.73M$-5,057,000
    Interest Income$1.95M$1.85M$1.89M$1.81M$1.66M$1.66M$1.56M$1.58M$1.51M$1.76M$1.44M$1.26M
    Interest Expense$160,000$160,000$162,000$158,000$157,000$153,000$154,000$154,000$153,000$153,000$156,000$150,000
    Income Before Tax$2.21M$-6,302,000$24.10M$5.07M$-553,000$-11,246,000$19.95M$-901,000$-4,682,000$-3,862,000$14.09M$-3,946,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$-286,000
    Net Income$2.21M$-6,302,000$23.24M$5.07M$-553,000$-11,246,000$19.81M$-901,000$-4,682,000$-3,862,000$12.99M$-3,660,000
    EBITDA$4.03M$-4,699,000$25.58M$6.35M$774,000$-10,129,000$19.96M$-1,123,000$-4,925,000$-4,141,000$13.98M$-4,135,000
    EBIT$412,000$-7,993,000$22.38M$3.42M$-2,053,000$-12,750,000$18.55M$-2,325,000$-6,039,000$-5,471,000$12.81M$-5,058,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VCEL

    News

    Madison Asset Management LLC Acquires Shares of 50,116 Vericel Corporation $VCEL

    Madison Asset Management LLC has acquired 50,116 shares of Vericel Corporation (NASDAQ:VCEL), valued at approximately $2.23 million, representing a new position for the firm. Other institutional investors like BlackRock Inc. and TimesSquare Capital Management LLC also increased their stakes. The article also details recent insider stock sales by Vericel's CFO and another insider, stock performance data, and updated analyst ratings for VCEL.

    MarketBeat•8/21/26•
    Somewhat-Bullish

    Summit Creek Advisors LLC Purchases Shares of 219,312 Vericel Corporation $VCEL

    Summit Creek Advisors LLC has acquired 219,312 shares of Vericel Corporation (NASDAQ:VCEL), valued at approximately $9.76 million, making it their second-largest holding. Other institutions like BlackRock and TimesSquare Capital also initiated new positions, while State Street, GW&K, and Goldman Sachs increased their stakes. Vericel recently reported strong quarterly earnings, exceeding analyst estimates with $77.46 million in revenue and $0.04 EPS.

    MarketBeat•8/19/26•
    Bullish

    TimesSquare Capital Management LLC Invests $24.46 Million in Vericel Corporation $VCEL

    TimesSquare Capital Management LLC has invested $24.46 million in Vericel Corporation (VCEL), acquiring 549,846 shares. Other institutional investors have also increased their holdings, while company insiders sold shares. Analyst sentiment is generally positive, with a "Moderate Buy" consensus and an average price target of $58.40, following strong quarterly earnings that exceeded expectations.

    MarketBeat•8/18/26•
    Bullish

    Vericel Corporation $VCEL Shares Purchased by Bank of America Corp DE

    Bank of America Corp DE significantly increased its stake in Vericel Corporation (NASDAQ:VCEL) during the first quarter, purchasing an additional 180,761 shares to own a total of 1.10 million shares valued at $35.3 million. This investment follows a strong financial performance by Vericel, which reported quarterly revenue of $77.46 million, a 22.5% year-over-year increase, and an EPS of $0.04, surpassing analyst expectations. Despite insider selling of 52,232 shares worth approximately $2.3 million in the past three months, analysts maintain a "Moderate Buy" rating for VCEL, with an average price target of $58.40.

    MarketBeat•8/15/26•
    Bullish

    Vericel Corp Director Kevin McLaughlin Executes Stock Options and Sells Shares Under 10b5-1 Plan

    Vericel Corp (NASDAQ:VCEL) Director Kevin F. McLaughlin exercised stock options for 7,000 shares at $13.05 per share and subsequently sold those shares at $44.53 per share on August 12, 2026. These transactions were carried out under a pre-established Rule 10b5-1 trading plan adopted in May 2025. Following the sale, McLaughlin directly holds 18,300 shares of common stock and 7,000 stock options.

    Kalkine Media•8/15/26•
    Neutral

    Frequently Asked Questions About VCEL

    Does VCEL pay dividends?
    Vericel Corp Ord (VCEL) does not currently pay a regular dividend.
    What is VCEL's P/E ratio?
    Vericel Corp Ord has a price-to-earnings (P/E) ratio of 84.89.
    What is VCEL's market cap?
    Vericel Corp Ord (VCEL) has a market capitalization of $2.10B with a current stock price of $39.90.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In